Please login to the form below

Not currently logged in
Email:
Password:

BIND Biosciences

This page shows the latest BIND Biosciences news and features for those working in and with pharma, biotech and healthcare.

Amgen signs $180m nanotechnology cancer deal

Amgen signs $180m nanotechnology cancer deal

Amgen signs $180m nanotechnology cancer deal. Will combine BIND Biosciences' tissue-targeting technology with a molecularly-targeted drug. ... Amgen has teamed up with nanotechnology specialist BIND Biosciences to develop a new version of one of its

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Use of biomarkers in marketing

    Mark Assenti is a Senior Associate Consultant at Blue Latitude. Mark began his career in the biosciences field, studying genetics at Cardiff University.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics